Categories: News

Cellebrite to Report First-Quarter 2026 Financial Results on May 14, 2026

TYSONS CORNER, Va. and PETAH TIKVA, Israel, April 21, 2026 /PRNewswire/ — Cellebrite DI Ltd. (NASDAQ: CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, today announced it will report its first-quarter 2026 financial results before the U.S. markets open on Thursday, May 14, 2026.

- Advertisement -

Later that same morning, Cellebrite will host a live conference call and webcast to review the Company’s financial results for the first quarter of 2026 and discuss its 2026 outlook. Relevant details include:

- Advertisement -

Date:

Thursday, May 14, 2026

Time:

8:30 a.m. ET

Call-In Number:

203-518-9814 / 800-274-8461

Conference ID: 

CLBTQ126

Event URL:

https://investors.cellebrite.com/events/event-details/cellebrite-q1-2026-financial-results-conference-call-webcast

Live Webcast URL:

https://edge.media-server.com/mmc/p/7b5rowvx

In conjunction with the conference call and webcast, historical financial tables and supplemental data will be available on the quarterly results section of Company’s investor relations website at https://investors.cellebrite.com/financial-information/quarterly-results.

- Advertisement -

About Cellebrite
Cellebrite’s (Nasdaq: CLBT) mission is to protect communities, nations and businesses as a global leader in digital investigative and intelligence solutions. More than 7,000 global law enforcement agencies, defense and intelligence organizations and enterprises trust Cellebrite’s AI-powered software portfolio to make forensically sound digital data more accessible and actionable. Cellebrite technology allows customers to accelerate nearly 3 million legally sanctioned investigations annually, enhance sovereign security, elevate operational efficacy and efficiency and enable advanced mobile research and application security. Available via cloud, on-premises and hybrid deployments, Cellebrite’s technology enables its customers around the globe to advance their missions, elevate public safety and safeguard data privacy. To learn more, visit us at www.cellebrite.com, https://investors.cellebrite.com/investors and find us on social media @Cellebrite.

- Advertisement -

Investor Relations
Andrew Kramer
Vice President, Investor Relations
investors@cellebrite.com
+1 973.206.7760

- Advertisement -

Media
Victor Cooper
Sr. Director of Corporate Communications + Content Operations
Victor.cooper@cellebrite.com
+1 404.804.5910

- Advertisement -

Logo – https://mma.prnewswire.com/media/2855183/5926073/Cellebrite_Logo.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/cellebrite-to-report-first-quarter-2026-financial-results-on-may-14-2026-302747799.html

- Advertisement -

Recent Posts

Waters Unveils Cyclic IMS P20 MS: The New Benchmark in Structural and Spatial Omics

>10x step-change in MS/MS sensitivity paired with multipass Cyclic™ Ion Mobility Spectrometry (IMS) reveals subtle…

3 hours ago

Phenomenex Launches Endrix Long Life Columns, Redefining Column Durability and Method Reliability

Redefined Column Durability and Method ReliabilityTORRANCE, Calif., June 1, 2026 /PRNewswire/ -- Phenomenex Inc., a…

3 hours ago

Waters Introduces Unrivaled Sensitivity and Speed to Benchtop HRMS with Xevo MRT P10 MS, Accelerating Multiomics Research

Delivers up to 20x improvement in MS/MS sensitivity and 2x faster acquisition speeds, enabling deeper…

3 hours ago

Rare Redo Bentall Surgery Successfully Performed on 72-Year-Old Patient from Mizoram at Manipal Hospital

KOLKATA, India, June 1, 2026 /PRNewswire/ -- A 72-year-old man from Mizoram, has successfully undergone rare…

3 hours ago

Cipla Health touches 1500+ lives through multi-city on-ground screening and awareness initiatives on World No Tobacco Day

The initiative focuses on early detection and bridging the gap between intent and sustained quittingMUMBAI,…

3 hours ago